This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination

"Annual skin cancer screenings are critically important because they can catch skin cancer, including melanoma, in its earliest, most curable stage," said Darrell Rigel, MD, Clinical Professor of Dermatology, New York University. "I advise my patients to monitor their moles on an ongoing basis and to come into the office for a professional full-body skin cancer screening at least once a year."

Annual ExamsThe survey findings show that the majority of American adults (86%) have had a physical exam by a physician but that Americans are less likely to have had a skin cancer screening by a dermatologist. Older adults are significantly more likely to have had a skin cancer screening, compared to their younger counterparts (40% of those ages 55+ vs. 16% of those ages 18-54), even though melanoma is one of the more common cancers in people younger than 30. 1

Survey findings also show that 26% of American women have had a skin cancer screening by a dermatologist, compared to 23% of men. Adults in the Northeast (28%) and South (25%) are significantly more likely to have had a skin cancer screening than those who live in the Midwest (19%).

Self-ExamsThe survey found that more than half (51%) of Americans do not regularly conduct monthly self-exams including breast, testicular and mole checks. Women are more likely to perform monthly mole self-checks than men (26% and 19%, respectively). Interestingly, a larger percentage of adults who have had a skin cancer screening by a dermatologist perform monthly mole self-checks (39%).

Cancer RiskEven with advancements in sun protection technology and education on the importance of sunscreen in protecting against the risks of skin cancer, the survey shows that over two in five (43%) of U.S. adults say skin cancer "is not something they worry about." Younger men are significantly more likely to say they do not believe they are at risk for skin cancer than their older counterparts (45% of men ages 18-44, 33% of men ages 55+). 37% of Americans also agree that melanoma is treatable, no matter "what stage it is caught."

"We continue to push the need for self-exams at home and screenings by board-certified dermatologists, as the combination of both exams gives a higher likelihood of identifying skin cancer at earlier stages," said Laura K. Ferris, MD, PhD, Assistant Professor of Dermatology, University of Pittsburgh Medical Center. "We know that some consumers may look at smartphone applications for guidance, but my recent study shows that these apps are not reliable tools, with three out of four applications incorrectly classifying 30% or more of melanomas as unconcerning. 2 There is simply no substitute for seeing a dermatologist for a full skin cancer screening."

"During our skin cancer screenings, we now have the advantage of using MelaFind® on unusual moles which helps us learn about the characteristics of a mole, said Dr. Rigel. "In turn, we're becoming better diagnosticians and are better able to identify melanoma in its most curable stages."

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs